Risk and impact of tuberculosis in patients with multiple myeloma*

References

• Rollig C, Knop S, Bornhauser M. Multiple myeloma. Lancet. 2015;385:2197–2208.
   PubMed Web of Science ®Google Scholar
• Palumbo A, Anderson K. Multiple myeloma. N Engl J Med. 2011;364:1046–1060.
   PubMed Web of Science ®Google Scholar
• Howlader N, Noone AM, Krapcho M, et al (eds). SEER Cancer Statistics Review, 1975?2013 [cited 2016 April]. Bethesda, MD: National Cancer Institute. Available from: http://seer.cancer.gov/csr/1975_2013/, based on November 2015 SEER data submission.
   Google Scholar
• Munshi NC, Longo DL, Anderson KC, Plasma cell disorders. In: Kasper DL, Fauci AS, Longo DL, Hauser SL, Jameson JL, Loscalzo J. Harrison's principles of internal medicine. 19th ed. Vol 1. New York: McGraw-Hill; 2015. p. 712.
   Google Scholar
• Laura A, Anna D, Dennis F, et al. Global tuberculosis report. 20th ed. Geneva, Switzerland: World Health Organization; 2015, p. 1.
   Google Scholar
• Kamboj M, Sepkowitz KA. The risk of tuberculosis in patients with cancer. Clin Infect Dis. 2006;42:1592–1595.
   PubMed Web of Science ®Google Scholar
• Ahn JS, Rew SY, Yang DH, et al. Poor prognostic significance of Mycobacterium tuberculosis infection during bortezomib-containing chemotherapy in patients with multiple myeloma. Blood Res. 2013;48:35–39.
   PubMedGoogle Scholar
• Mills KH, Cawley JC. Abnormal monoclonal antibody-defined helper/suppressor T-cell subpopulations in multiple myeloma: relationship to treatment and clinical stage. Br J Haematol. 1983;53:271–275.
   PubMed Web of Science ®Google Scholar
• Brown RD, Pope B, Murray A, et al. Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-beta1 and interleukin-10. Blood. 2001;98:2992–2998.
   PubMed Web of Science ®Google Scholar
• Ogawara H, Handa H, Yamazaki T, et al. High Th1/Th2 ratio in patients with multiple myeloma. Leuk Res. 2005;29:135–140.
   PubMed Web of Science ®Google Scholar
• Ratta M, Fagnoni F, Curti A, et al. Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6. Blood. 2002;100:230–237.
   PubMed Web of Science ®Google Scholar
• Muthu Raja KR, Kubiczkova L, Rihova L, et al. Functionally suppressive CD8 T regulatory cells are increased in patients with multiple myeloma: a cause for immune impairment. PLoS One. 2012;7:e49446.
   PubMed Web of Science ®Google Scholar
• Philips JA, Ernst JD. Tuberculosis pathogenesis and immunity. Annu Rev Pathol. 2012;7:353–384.
   PubMed Web of Science ®Google Scholar
• Chien-Yuan Chen W-HS, Cheng A, Tsay W, Huang S-Y, Tang J-L, Chen Y-C, Wang J-Y, Tien H-F, Chang S-C. Clinical characteristics and outcomes of Mycobacterium tuberculosis disease in adult patients. BMC Infect Dis. 2011;11:324.
   PubMed Web of Science ®Google Scholar
• Fan WC, Liu CJ, Hong YC, et al. Long-term risk of tuberculosis in haematopoietic stem cell transplant recipients: a 10-year nationwide study. Int J Tuberc Lung Dis. 2015;19:58–64.
   PubMed Web of Science ®Google Scholar
• Cheng TM. Taiwan's new national health insurance program: genesis and experience so far. Health Aff (Millwood). 2003;22:61–76.
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2013, Apr 15). Definitions and reporting framework for tuberculosis. Available from: http://apps.who.int/iris/bitstream/10665/79199/1/9789241505345_eng.pdf.
   Google Scholar
• Stead WW, Lofgren JP. Does the risk of tuberculosis increase in old age? J Infect Dis. 1983;147:951–955.
   PubMed Web of Science ®Google Scholar
• Dooley KE, Chaisson RE. Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis. 2009;9:737–746.
   PubMed Web of Science ®Google Scholar
• Lee CH, Lee MC, Shu CC, et al. Risk factors for pulmonary tuberculosis in patients with chronic obstructive airway disease in Taiwan: a nationwide cohort study. BMC Infect Dis. 2013;13:194.
   PubMed Web of Science ®Google Scholar
• Cho YJ, Lee SM, Yoo CG, et al. Clinical characteristics of tuberculosis in patients with liver cirrhosis. Respirology. 2007;12:401–405.
   PubMed Web of Science ®Google Scholar
• Hu HY, Wu CY, Huang N, et al. Increased risk of tuberculosis in patients with end-stage renal disease: a population-based cohort study in Taiwan, a country of high incidence of end-stage renal disease. Epidemiol Infect. 2014;142:191–199.
   PubMed Web of Science ®Google Scholar
• Fujita T, Endo M, Gu Y, et al. Mycobacterium tuberculosis infection in cancer patients at a tertiary care cancer center in Japan. J Infect Chemother. 2014;20:213–216.
   PubMed Web of Science ®Google Scholar
• Kim DK, Lee SW, Yoo CG, et al. Clinical characteristics and treatment responses of tuberculosis in patients with malignancy receiving anticancer chemotherapy. Chest. 2005;128:2218–2222.
   PubMed Web of Science ®Google Scholar
• De La Rosa GR, Jacobson KL, Rolston KV, et al. Mycobacterium tuberculosis at a comprehensive cancer centre: active disease in patients with underlying malignancy during 1990–2000. Clin Microbiol Infect. 2004;10:749–752.
   PubMed Web of Science ®Google Scholar
• Boyd KD, Ross FM, Chiecchio L, et al. Gender disparities in the tumor genetics and clinical outcome of multiple myeloma. Cancer Epidemiol Biomarkers Prev. 2011;20:1703–1707.
   PubMed Web of Science ®Google Scholar
• Yusuf AA, Natwick T, Werther W, et al. A retrospective analysis to examine factors associated with mortality in Medicare beneficiaries newly diagnosed with multiple myeloma. Curr Med Res Opin. 2016;32:1989–1996.
   PubMed Web of Science ®Google Scholar
• Chen JH, Chung CH, Wang YC, et al. Prevalence and mortality-related factors of multiple myeloma in Taiwan. PLoS One. 2016;11:e0167227.
   PubMed Web of Science ®Google Scholar
• Costa LJ, Gonsalves WI, Kumar SK. Early mortality in multiple myeloma. Leukemia. 2015;29:1616–1618.
   PubMed Web of Science ®Google Scholar
• Hsu P, Lin TW, Gau JP, et al. Risk of Early Mortality in Patients With Newly Diagnosed Multiple Myeloma. Medicine (Baltimore). 2015;94:e2305.
   PubMed Web of Science ®Google Scholar
• El Husseiny NM, Kasem N, El Azeeim HA, et al. Multiple myeloma: a descriptive study of 217 Egyptian patients. Ann Hematol. 2014;93:141–145.
   PubMed Web of Science ®Google Scholar
• Volkmann T, Moonan PK, Miramontes R, et al. Tuberculosis and excess alcohol use in the United States, 1997-2012. Int J Tuberc Lung Dis. 2015;19:111–119.
   PubMed Web of Science ®Google Scholar
• Rehm J, Samokhvalov AV, Neuman MG, et al. The association between alcohol use, alcohol use disorders and tuberculosis (TB). A systematic review. BMC Public Health. 2009;9:450.
   PubMed Web of Science ®Google Scholar
• Zhang P, Bagby GJ, Happel KI, et al. Pulmonary host defenses and alcohol. Front Biosci. 2002;7:d1314–d1330.
   PubMed Web of Science ®Google Scholar
• Happel KI, Nelson S. Alcohol, immunosuppression, and the lung. Proc Am Thorac Soc. 2005;2:428–432.
   PubMedGoogle Scholar
• Sterling TR, Zhao Z, Khan A, et al. Mortality in a large tuberculosis treatment trial: modifiable and non-modifiable risk factors. Int J Tuberc Lung Dis. 2006;10:542–549.
   PubMed Web of Science ®Google Scholar
• Jick SS, Lieberman ES, Rahman MU, et al. Glucocorticoid use, other associated factors, and the risk of tuberculosis. Arthritis Rheum. 2006;55:19–26.
   PubMed Web of Science ®Google Scholar
• Kim HR, Hwang SS, Ro YK, et al. Solid-organ malignancy as a risk factor for tuberculosis. Respirology. 2008;13:413–419.
   PubMed Web of Science ®Google Scholar
• Arslan O, Gurman G, Dilek I, et al. Incidence of tuberculosis after bone marrow transplantation in a single center from Turkey. Haematologia (Budap). 1998;29:59–62.
   PubMedGoogle Scholar
• Krishnan N, Robertson BD, Thwaites G. The mechanisms and consequences of the extra-pulmonary dissemination of Mycobacterium tuberculosis. Tuberculosis (Edinb). 2010;90:361–366.
   PubMed Web of Science ®Google Scholar